Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke

被引：9
|
作者：
Kimura, Genjiro [1 ]
机构：
[1] Japan Org Occupat Hlth & Safety, Asahi Rosai Hosp, Hirako Cho North 61, Owariasahi 4888585, Japan
来源：
CIRCULATION JOURNAL | 2017年 / 81卷 / 06期
关键词：
CARDIOVASCULAR OUTCOMES; EMPAGLIFLOZIN; DISEASE;
D O I：
10.1253/circj.CJ-17-0040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：898 / 898
页数：1
相关论文
共 50 条
  • [41] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review (vol 5, pg 161, 2016)
    Kalra, Sanjay
    Sahay, Rakesh
    Baruah, Manash P.
    CARDIOLOGY AND THERAPY, 2016, 5 (02) : 169 - 169
  • [42] Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study
    Gamaza-Chulian, Sergio
    Diaz-Retamino, Enrique
    Gonzalez-Teston, Fatima
    Carlos Gaitero, Jose
    Jose Castillo, Maria
    Alfaro, Raquel
    Rodriguez, Elias
    Gonzalez-Caballero, Eva
    Martin-Santana, Antonio
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [43] A Pilot Study to Determine Outcomes in Lung Transplant Recipients Using Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors
    Kukrety, S. P.
    Singh, A.
    Brink, H.
    Bailey, K. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [44] Nephrologist Use of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Relative to Other Specialties, 2015-2022
    Adhikari, Rishav
    Jha, Kunal
    Blaha, Michael J.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 572 - 572
  • [45] Exploring the Cardiovascular Benefits of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: Expanding Horizons Beyond Diabetes Management
    Fatima, Aroob
    Rasool, Sohaib
    Devi, Sapna
    Talha, Muhammad
    Waqar, Fahad
    Nasir, Muhammad
    Khan, Mohammad R.
    Jaffari, Syed M. Ibne Ali
    Haider, Anum
    Shah, Syeda U.
    Sapna, Fnu
    Varrassi, Giustino
    Khatri, Mahima
    Kumar, Satesh
    Mohamad, Tamam
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [46] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Guardians against Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Heart Diseases
    Pham, Linh Thi Truc
    Mangmool, Supachoke
    Parichatikanond, Warisara
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (11) : 3279 - 3298
  • [47] The sodium-glucose cotransporter-2 (SGLT2) inhibitors synergize with nitric oxide and prostacyclin to reduce human platelet activation
    Lescano, Caroline Honaiser
    Leonardi, Guilherme
    Portugal Torres, Pedro Henrique
    Amaral, Tiago Nardi
    de Freitas Filho, Luiz Henrique
    Antunes, Edson
    Vicente, Cristina Pontes
    Anhe, Gabriel Forato
    Monica, Fabiola Zakia
    BIOCHEMICAL PHARMACOLOGY, 2020, 182
  • [48] Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors as a Dual Therapeutic Target for Cardiovascular and Renal Health: A Narrative Review
    Al Rashid, Sulthan
    Madar, Inamul Hasan
    Misbah, Iffath
    Dhanabalan, Kamalakannan
    Balasubramanian, Rajkapoor
    Maideen, Naina Mohamed Pakkir
    IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES, 2025,
  • [49] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors from Natural Products: Discovery of Next-Generation Antihyperglycemic Agents
    Choi, Chang-Ik
    MOLECULES, 2016, 21 (09)
  • [50] Physician experiences with sodium-glucose cotransporter (SGLT2) inhibitors, a new class of medications in type 2 diabetes, and adverse effects
    Patakfalvi, Laura
    Brazeau, Anne-Sophie
    Dasgupta, Kaberi
    PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT, 2019, 20
12345